Therefore, the FXR-ligands could be an effective therapeutic agent for fatty liver by affecting both lipid synthesis and degradation, in addition to the clinical benefits for the patients with PBC, NASH, and diabetes mellitus.(14–17). This evidence concerns the gene NR1H4 and fatty liver disease.